Health

U.S. FDA Approves Kerendia (finerenone) to Treat Patients with Heart Failure with Left Ventricular Ejection Fraction ≥40% Following Priority Review

DailyTrendDailyTrend
Jul 15, 2025 - 00:00
 0  0
U.S. FDA Approves Kerendia (finerenone) to Treat Patients with Heart Failure with Left Ventricular Ejection Fraction ≥40% Following Priority Review
WHIPPANY, N.J., July 14, 2025 – Bayer today announced that the U.S. Food and Drug Administration (FDA) approved Kerendia (finerenone) to treat patients with heart failure (HF) with left ventricular ejection fraction (LVEF) ≥40%, 1 following...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Medical Groups Warn Against Visa Fees for Foreign Doctors

Medical Groups Warn Against Visa Fees for Foreign Doctors

DailyTrend Sep 26, 2025  0  0

Trump’s Pharma Tariffs Spare Richest Drugmakers

Trump’s Pharma Tariffs Spare Richest Drugmakers

DailyTrend Sep 26, 2025  0  0

FDA Approves Palsonify (paltusotine) for the Treatment ...

DailyTrend Sep 29, 2025  0  0

Fragile N.C. Residents Lose Medicaid Support for Food and Housing

Fragile N.C. Residents Lose Medicaid Support for Food a...

DailyTrend Sep 30, 2025  0  0

What is an Early Alert?

What is an Early Alert?

DailyTrend Sep 30, 2025  0  0

Gunman in NYC Shooting at NFL Headquarters Had CTE

Gunman in NYC Shooting at NFL Headquarters Had CTE

DailyTrend Sep 26, 2025  0  0